These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Plasma concentration of lipoprotein(a) and the risk of future stroke. Ridker PM; Stampfer MJ; Hennekens CH JAMA; 1995 Apr; 273(16):1269-73. PubMed ID: 7715039 [TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women. Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458 [TBL] [Abstract][Full Text] [Related]
5. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Ridker PM; Hennekens CH; Cerskus A; Stampfer MJ Circulation; 1994 Nov; 90(5):2236-40. PubMed ID: 7955179 [TBL] [Abstract][Full Text] [Related]
6. Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women Study. Macko RF; Kittner SJ; Epstein A; Cox DK; Wozniak MA; Wityk RJ; Stern BJ; Sloan MA; Sherwin R; Price TR; McCarter RJ; Johnson CJ; Earley CJ; Buchholz DW; Stolley PD Stroke; 1999 Jan; 30(1):7-11. PubMed ID: 9880380 [TBL] [Abstract][Full Text] [Related]
7. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. Ridker PM; Vaughan DE; Stampfer MJ; Glynn RJ; Hennekens CH JAMA; 1994 Sep; 272(12):929-33. PubMed ID: 7794308 [TBL] [Abstract][Full Text] [Related]
8. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Smith FB; Lee AJ; Fowkes FG; Price JF; Rumley A; Lowe GD Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3321-5. PubMed ID: 9409328 [TBL] [Abstract][Full Text] [Related]
9. [Alterations of fibrinolysis in stroke]. Hernández Nuñez A; Romero Barbero JL; Cáceres Sansaloni A; Pérez de Oteyza C An Med Interna; 1996 Mar; 13(3):107-10. PubMed ID: 8679836 [TBL] [Abstract][Full Text] [Related]
10. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Ridker PM; Hennekens CH; Schmitz C; Stampfer MJ; Lindpaintner K Lancet; 1997 Feb; 349(9049):385-8. PubMed ID: 9033464 [TBL] [Abstract][Full Text] [Related]
11. Body mass index and thromboembolic stroke in nonsmoking men in older middle age. The Honolulu Heart Program. Abbott RD; Behrens GR; Sharp DS; Rodriguez BL; Burchfiel CM; Ross GW; Yano K; Curb JD Stroke; 1994 Dec; 25(12):2370-6. PubMed ID: 7974575 [TBL] [Abstract][Full Text] [Related]
12. Increased fibrinogen levels and acquired hypofibrinolysis in young adults with ischemic stroke. Kristensen B; Malm J; Nilsson TK; Hultdin J; Carlberg B; Olsson T Stroke; 1998 Nov; 29(11):2261-7. PubMed ID: 9804632 [TBL] [Abstract][Full Text] [Related]
14. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Perry IJ; Refsum H; Morris RW; Ebrahim SB; Ueland PM; Shaper AG Lancet; 1995 Nov; 346(8987):1395-8. PubMed ID: 7475822 [TBL] [Abstract][Full Text] [Related]
15. [Role of the fibrinolytic system in the physiology of stroke]. Raya Sánchez JM; Hernández Nieto L An Med Interna; 1996 Mar; 13(3):105-6. PubMed ID: 8679835 [No Abstract] [Full Text] [Related]
16. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Ridker PM; Hennekens CH; Roitman-Johnson B; Stampfer MJ; Allen J Lancet; 1998 Jan; 351(9096):88-92. PubMed ID: 9439492 [TBL] [Abstract][Full Text] [Related]
18. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study. Lowe GD; Yarnell JW; Sweetnam PM; Rumley A; Thomas HF; Elwood PC Thromb Haemost; 1998 Jan; 79(1):129-33. PubMed ID: 9459337 [TBL] [Abstract][Full Text] [Related]
19. Treatment with tPA predicts better outcome even if MCA occlusion persists. Kablau M; Alonso A; Hennerici MG; Fatar M Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025 [TBL] [Abstract][Full Text] [Related]
20. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations]. Rabijewski M; Zgliczyński W Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]